A detailed history of Nicholas Hoffman & Company, Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 25,654 shares of AZN stock, worth $1.93 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
25,654
Previous 25,644 0.04%
Holding current value
$1.93 Million
Previous $2 Million 0.05%
% of portfolio
0.09%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$76.67 - $87.62 $766 - $876
10 Added 0.04%
25,654 $2 Million
Q2 2024

Aug 02, 2024

SELL
$66.81 - $80.83 $24,185 - $29,260
-362 Reduced 1.39%
25,644 $2 Million
Q1 2024

Apr 22, 2024

BUY
$61.03 - $69.57 $40,584 - $46,264
665 Added 2.62%
26,006 $1.76 Million
Q4 2023

Jan 31, 2024

BUY
$61.89 - $69.28 $29,397 - $32,908
475 Added 1.91%
25,341 $1.71 Million
Q3 2023

Nov 06, 2023

BUY
$64.85 - $71.7 $45,135 - $49,903
696 Added 2.88%
24,866 $1.68 Million
Q2 2023

Aug 09, 2023

BUY
$69.91 - $75.81 $14,051 - $15,237
201 Added 0.84%
24,170 $1.73 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $884 - $1,002
14 Added 0.06%
23,969 $1.66 Million
Q3 2022

Nov 04, 2022

SELL
$53.02 - $135.75 $2,651 - $6,787
-50 Reduced 0.21%
23,955 $1.31 Million
Q2 2022

Aug 09, 2022

SELL
$59.26 - $71.14 $32,355 - $38,842
-546 Reduced 2.22%
24,005 $1.59 Million
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $780 - $939
14 Added 0.06%
24,551 $1.63 Million
Q3 2021

Nov 04, 2021

SELL
$55.56 - $60.79 $134,677 - $147,354
-2,424 Reduced 8.99%
24,537 $1.47 Million
Q1 2021

May 11, 2021

SELL
$47.16 - $54.44 $102,950 - $118,842
-2,183 Reduced 7.49%
26,961 $1.34 Million
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $48,520 - $58,020
1,000 Added 3.55%
29,144 $1.46 Million
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $119,407 - $137,475
2,250 Added 8.69%
28,144 $1.54 Million
Q2 2020

Aug 12, 2020

BUY
$43.1 - $55.31 $7,068 - $9,070
164 Added 0.64%
25,894 $1.37 Million
Q1 2020

May 11, 2020

SELL
$37.79 - $51.33 $154,447 - $209,785
-4,087 Reduced 13.71%
25,730 $1.15 Million
Q3 2019

Nov 12, 2019

BUY
$40.12 - $45.47 $77,311 - $87,620
1,927 Added 6.91%
29,817 $1.33 Million
Q2 2019

Aug 12, 2019

BUY
$37.28 - $41.68 $102,520 - $114,620
2,750 Added 10.94%
27,890 $1.15 Million
Q1 2019

May 13, 2019

SELL
$35.49 - $43.02 $102,104 - $123,768
-2,877 Reduced 10.27%
25,140 $1.02 Million
Q4 2018

Feb 08, 2019

SELL
$36.86 - $41.49 $19,277 - $21,699
-523 Reduced 1.83%
28,017 $1.06 Million
Q2 2018

Aug 07, 2018

SELL
$34.55 - $37.05 $23,148 - $24,823
-670 Reduced 2.29%
28,540 $1 Million
Q1 2018

May 07, 2018

SELL
$32.97 - $36.63 $6,231 - $6,923
-189 Reduced 0.64%
29,210 $1.02 Million
Q3 2017

Nov 13, 2017

SELL
$28.96 - $34.0 $10,251 - $12,036
-354 Reduced 1.19%
29,399 $996,000
Q2 2017

Aug 14, 2017

BUY
N/A
29,753
29,753 $1.01 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nicholas Hoffman & Company, Llc. Portfolio

Follow Nicholas Hoffman & Company, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.